Late side-effects during systemic immunotherapy in children

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 63, Issue 11, 2008, Pages 1561-1562

  Caubet, J C ^b   Eigenmann, P A ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE

Author keywords

Anaphylaxis; Asthma; Children; Immunotherapy; Side effects

Indexed keywords

HYMENOPTERA VENOM; IMMUNOLOGIC AGENT;

ALLERGIC RHINITIS; ANAPHYLACTIC SHOCK; ARTICLE; ASTHMA; DELAYED HYPERSENSITIVITY; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; HUMAN; IMMUNOTHERAPY; INSECT ALLERGY; INSECT BITE; PRIORITY JOURNAL; PRURITUS; RESPIRATORY TRACT ALLERGY;

CHILD; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; INCIDENCE; INJECTIONS, SUBCUTANEOUS; SWITZERLAND;

EID: 53749103354     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2008.01868.x     Document Type: Article

References (6)

1. Alvarez-Cuesta E, Bousquet J, Canonica GW, Durham SR, Malling H-J, Valovirta E. EAACI, Immunotherapy Task Force, Standards for practical allergen-specific immunotherapy. Allergy 2006;61:1-20.
2. Bousquet J, Lockey R, Malling HJ. WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998;53(Suppl. 44):1-42.
3. Nelson Harold S. Efficacy and safety of allergen immunotherapy in children. Ann Allergy Asthma Immunol 2006;96:S2-S5.
4. Malling H-J, Weeke B, editors. EAACI Position Paper. Immunotherapy. Allergy 1993;48(Suppl. 14):9-35
5. Mellerup MT, Hahn GW, Poulsen LK, Malling HJ. Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment. Clin Exp Allergy 2000;30:1423-1429.
6. Gastaminza J, Algorta J, Audicana M, Etxenagusia M, Fernandez E, Munoz D. Systemic reactions to immunotherapy: influence of composition and manufacter. Clin Exp Allergy 2003;33:470-474.